Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.

Cañete, J D; Suárez, B; Hernández, M V; Sanmartí, R; Rego, I; Celis, R; Moll, C; Pinto, J A; Blanco, F J; Lozano, F

Cañete, J D; Suárez, B; Hernández, M V; Sanmartí, R; Rego, I; Celis, R; Moll, C; Pinto, J A; Blanco, F J; Lozano, F.

Affiliation

Cañete JD; Rheumatology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, School of Medicine, University of Barcelona, Barcelona, Spain. jcanete@clinic.ub.es

Ann Rheum Dis ; 68(10): 1547-52, 2009 Oct.

Article in En | MEDLINE | ID: mdl-18930989

Subject(s)

Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/drug therapy; Arthritis, Rheumatoid/genetics; Receptors, IgG/genetics; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adult; Aged; Antibodies, Monoclonal/therapeutic use; Female; Follow-Up Studies; Genotype; Humans; Infliximab; Male; Middle Aged; Polymorphism, Single Nucleotide; Severity of Illness Index; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Tumor Necrosis Factor-alpha / Receptors, IgG / Antirheumatic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Rheum Dis Year: 2009 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google